Abstract:Objectives Depression is becoming a growing cause of disability, suicides and disease burden. It incurred substantial costs to societies all over the world. Estimating the medical costs of depression will provide implications for related policies and interventions. However, there is scarce of evidence on the economic costs of depression in China. The aim of this study is to assess depression-related medical service utilisation, the direct medical costs of depression and potential associated factors.Settings This study used data that comprised 5% random sample of claims data from China’s Urban Basic Medical Insurance between January 2013 and December 2016. Beneficiaries’ demographic information, diagnoses and cost of outpatient and inpatient services were recorded in the data set.Participants 26 123 patients with depression were identified as the study population in this study.Primary and secondary outcome measures The information on health service utilisation and cost was extracted based on the condition that depression was claimed as the index disease.Results From 2013 to 2016, weighted average annual total medical cost of depression in urban China was RMB2706.92, and the annual out-of-pocket cost was RMB786.4. The annual total medical cost of depression among urban residents in China was estimated to be 4.4 billion RMB (95% CI 4.15 to 4.67) (US$ 0.70, 95% CI 0.66 to 0.74). Nearly 65% of medical costs (RMB 1795.7 or US$ 285.0) were accounted by inpatient expenditure, and tertiary hospitals were the main provider of depression treatment. Depression-related medical care utilisation and direct costs were associated with gender, age, insurance status, severity of depression and diagnosis. Medication costs and medical service contributed to 41.7% and 56.6% of the average depression-related medical costs.Conclusion Depression poses a considerable burden on both the health system and the individual in urban China. Specific policies to strengthen the mental health resources in primary and secondary hospitals are in urgent need, and effective treatment strategies are important to prevent a progression and recurrence of depression, as well as an increase in medical cost.

Economic Burden of Schizophrenia:Based on Medical Insurance Database from Guangzhou

Burden of schizophrenia:A review

The Economic Burden Of Schizophrenia In The United States In 2002

A study on the changing trend and influencing factors of hospitalization costs of schizophrenia in economically underdeveloped areas of China

The Economic Burden of Patients with Mental Illness in Shandong Province during 2005 to 2013

[Community-Based Study on Disease Burden of Diarrhea in Zhejiang Province].

The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016

Study on Economic Burden of Mood Disorder Inpatients from one Tertiary Mental Health Hospital in Shanghai

Direct Medical Costs of Hospitalisations for Mental Disorders in Shanghai, China: a Time Series Study

Regional years of life lost, years lived with disability, and disability-adjusted life-years for severe mental disorders in Guangdong Province, China: a real-world longitudinal study

Pilot Evaluation of Economic Burden of Anxiety Disorders in Patients from Psychiatric Hospitals in Beijing Urban Area

Economic Burden and Influencing Factor Analysis of Outpatients with Epilepsy: A Cross-Sectional Study in Shanghai, Shanxi and Sichuan

Medical Service Utilisation and Direct Medical Cost of Depression: a Cross-Sectional Analysis of Urban Medical Claims Data from China.

Household economic burden and outcomes of patients with schizophrenia after being unlocked and treated in rural China

Individual and Societal Impact on Earnings Associated with Serious Mental Illness in Metropolitan China.

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data

Size of burden of schizophrenia and psychotic disorders

Medical expenses of patients with severe mental disorders in Beijing, China

Economic burden of epilepsy in a developing country: a retrospective cost analysis in China

A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China

Economic Costs Attributable to Modifiable Risk Factors: an Analysis of 24 Million Urban Residents in China